Canadian Pharmacy Platform to Facilitate India-Sourced Ozempic Sales for US Patients

Could your next refill come from across the ocean? According to Reuters, a Canadian pharmacy platform is now offering India-sourced Ozempic to US patients, signaling a bold shift in how Americans access high-cost weight-loss treatments.

India-Sourced Ozempic Sales: Bypassing High US Costs

With the price of Ozempic often exceeding $1,000 per month in the United States, patients are increasingly desperate for alternatives. The Canadian platform acts as an intermediary, sourcing the drug from regulated manufacturers in India where production costs are significantly lower. This move aims to provide price relief as the demand for semaglutide continues to outpace domestic supply.

The Regulatory Grey Area and Patient Safety

While this offers a financial lifeline, it lands in a regulatory grey area. The FDA typically restricts the importation of unapproved foreign drugs for personal use. However, the sheer scale of the US weight-loss drug shortage has forced many to look toward cross-border trade. Experts suggest this could prompt a stricter crackdown or, conversely, a faster track for affordable generic alternatives.